Zobrazeno 1 - 6
of 6
pro vyhledávání: '"E.G. Bana"'
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 42, Iss , Pp 557- (2020)
Externí odkaz:
https://doaj.org/article/d5fb20cd3ba8492f8e641a4a5797c4a9
Autor:
A.C. Senegaglia, C.L.K. Rebelatto, C.L. Franck, J.S. Lima, D.R. Daga, P. Shigunov, A.P. Azambuja, E.G. Bana, A.C. Dominguez, P.R.S. Brofman
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 42, Iss , Pp 564-565 (2020)
Externí odkaz:
https://doaj.org/article/db3c0f26ac404eda87f9ab81f1ed4641
Autor:
J.S. Lima, A.A.K. Johann, L. Ribeiro, B.S.L. Wan-Dall, E.G. Bana, E.C. Ditzel, V.B. Nocera, A.C. Menezes
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 42, Iss , Pp 551-552 (2020)
Externí odkaz:
https://doaj.org/article/5ddd02ccfe404108bb487d3319568f72
Autor:
V.B. Nocera, A.A.K. Johann, E.C. Ditzel, E.G. Bana, L. Ribeiro, J.S. Lima, B.S.L. Wan-Dall, A.C. Menezes
Publikováno v:
Hematology, Transfusion and Cell Therapy
Hematology, Transfusion and Cell Therapy, Vol 42, Iss, Pp 551-552 (2020)
Hematology, Transfusion and Cell Therapy, Vol 42, Iss, Pp 551-552 (2020)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23db39889aaffd477319172b80dda174
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 42, Iss, Pp 557-(2020)
Hematology, Transfusion and Cell Therapy
Hematology, Transfusion and Cell Therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36dc19e56817d382e8b914de051642a7
http://www.sciencedirect.com/science/article/pii/S253113792031227X
http://www.sciencedirect.com/science/article/pii/S253113792031227X
USE OF TOCILIZUMAB AND MESENCHYMAL STROMAL CELLS IN THE TREATMENT OF SEVERE COVID-19 - A CASE REPORT
Autor:
DB Marsaro, Isadora M. Vaz, Claudio Luciano Franck, Daga, B Schaidt, Lisandro Ribeiro, Valderez Ravaglio Jamur, Y Schluga, A Micosky, Prs Brofman, J.S. Lima, Patrícia Shigunov, E.G. Bana, Lmb Leite, Alexandra Cristina Senegaglia, Alejandro Correa, AP Azambuja, Clk Rebelatto
Publikováno v:
Cytotherapy
Currently, there is no specific treatment for coronavirus disease, and some drugs and cell-based therapy have been tested as alternatives This work aims to evaluate the effects of the combined use of humanized recombinant monoclonal antibody capable
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1e99d98f23ed058d5c72ce1c45e9add
http://europepmc.org/articles/PMC8079859
http://europepmc.org/articles/PMC8079859